Rank 40 • MedTech & Devices
Synchron
Develops an endovascular brain-computer interface implanted via blood vessels to restore motor control signals.
Visit website- Signal Score
- 88.5
- Total raised
- $145M
- Stage
- Series C
- Founded
- 2016
- Headquarters
- Brooklyn, USA
- Region
- North America
Their signal
With its unique catheter-delivered neuroprosthetic, the company bypasses highly invasive open-brain surgery, yielding impressive early safety profiles and rapid progress in clinical trial enrollments.
Signal Score 88.5editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.